Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Franzeck, Fabian C ^a,b,c   Ngwale, Ramadhani ^b   Msongole, Bernadeta ^b,e   Hamisi, Marian ^b,e   Abdul, Omary ^b,e   Henning, Lars ^a,b,c   Letang, Emilio ^a,b,c,f   Mwaigomole, Geoffrey ^b,c   Battegay, Manuel ^c,d   Hatz, Christoph ^a,b,c   Tanner, Marcel ^a,b,c  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Saint Francis Referral Hospital   (Tanzania)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY;

ANTIGEN DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEPATITIS B; HEPATITIS B RAPID TEST; HEPATITIS C; HEPATITIS C RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POINT OF CARE TESTING; PREDICTIVE VALUE; PROSPECTIVE STUDY; RURAL POPULATION; SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TANZANIA; VIRUS HEPATITIS;

ADULT; COMORBIDITY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; TANZANIA;

EID: 84874578136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058468     Document Type: Article

References (35)

1. World Health Organisation (2011) Global HIV/AIDS resonse; epidemic update and health sector progress towards Universal Access. Progress report 2011.
2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. The Lancet 372: 293-299.
3. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, et al. (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166: 1632-1641.
4. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
5. Hoffmann CJ, Thio CL, (2007) Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7: 402-409.
6. World Health Organization (2008) Hepatitis B Factsheet.
7. Thio CL, Smeaton L, Saulynas M, Hwang H, Saravan S, et al. (2012) Characterization of HIV-HBV co-infection in a multi-national HIV-infected cohort. AIDS.
8. Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, et al. (2011) High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther 16: 405-411.
9. de Vries-Sluijs TEMS, Reijnders JGP, Hansen BE, Zaaijer HL, Prins JM, et al. (2010) Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology 139: 1934-1941.
10. Matthews GV, Cooper DA, Dore GJ, (2007) Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. Antivir Ther 12: 119-122.
11. Martin-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, et al. (2011) Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 25: 73-79.
12. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents, 2010 revision.
13. Ministry of Health and Social Welfare of Tanzania (2009) National Guidelines for the Management of HIV and AIDS. Dar es Salaam, Tanzania.
14. Mossdorf E, Stoeckle M, Mwaigomole EG, Chiweka E, Kibatala PL, et al. (2011) Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infect Dis 11: 98.
15. Kirkwood B, Sterne J (2003) Essential Medical Statistics. Chichester, United Kingdom: Wiley-Blackwell.
16. Li J, Fine J, (2004) On sample size for sensitivity and specificity in prospective diagnostic accuracy studies. Stat Med 23: 2537-2550.
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138: W1-12.
18. Nash D, Katyal M, Brinkhof MW, Keiser O, May M, et al. (2008) Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22: 2291-2302.
19. Stahel E, Tanner M, Gyr N, Weiss N, Hess C, et al. (1984) Seroepidemiology of hepatitis B virus in rural Tanzania: relation of hepatitis B markers and liver function tests in patients with clinical liver disease and in healthy controls. East Afr Med J 61: 806-811.
20. Nagu TJ, Bakari M, Matee M, (2008) Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 8: 416.
21. Kew MC, (1996) Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 38Suppl 2: S31-36.
22. Ministry of Health and Social Welfare of Tanzania (2012) National Guidelines for the Management of HIV and AIDS. Dar es Salaam, Tanzania.
23. Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, et al. (2010) Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol 48: 3223-3230.
24. Randrianirina F, Carod JF, Ratsima E, Chretien JB, Richard V, et al. (2008) Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar. J Virol Methods 151: 294-297.
25. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pai NP (2012) Rapid Point-of-Care First-Line Screening Tests for Hepatitis B Infection: A Meta-Analysis of Diagnostic Accuracy (1980-2010). Am J Gastroenterol.
26. Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Hart IJ, et al. (2008) Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect 57: 72-77.
27. Davies J, van Oosterhout JJ, Nyirenda M, Bowden J, Moore E, et al. (2010) Reliability of rapid testing for hepatitis B in a region of high HIV endemicity. Trans R Soc Trop Med Hyg 104: 162-164.
28. Hoffmann CJ, Dayal D, Cheyip M, McIntyre JA, Gray GE, et al. (2012) Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. Int J STD AIDS 23: e10-13.
29. Jaroszewicz J, Reiberger T, Meyer-Olson D, Mauss S, Vogel M, et al. (2012) Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection. PLoS One 7: e43143.
30. Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, et al. (1993) Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18: 497-502.
31. Chan ED, Heifets L, Iseman MD, (2000) Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis 80: 131-140.
32. Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ, (2012) HIV-HBV coinfection-a global challenge. N Engl J Med 366: 1749-1752.
33. European AIDS Clinical Society (EACS) (2011) Guidelines for the clinical management and treatment of HIV infected adults.
34. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. Jama 308: 387-402.
35. Tess BH, Levin A, Brubaker G, Shao J, Drummond JE, et al. (2000) Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Am J Trop Med Hyg 62: 138-141.